Status:
COMPLETED
A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix
Lead Sponsor:
Tata Memorial Hospital
Collaborating Sponsors:
Varian Medical Systems
Conditions:
Cancer of Cervix
Eligibility:
FEMALE
18-65 years
Brief Summary
A study to evaluate the efficacy of Intensity Modulated Radiation Therapy (IMRT) as compared to Standard Conventional Radiotherapy Alone in the treatment of carcinoma cervix. Concomitant Weekly Cispla...
Detailed Description
Carcinoma Cervix is the commonest malignancy seen in Indian women and constitutes approximately 10% of all cancers at Tata Memorial Hospital (1). It is also the leading cause of cancer mortality in In...
Eligibility Criteria
Inclusion
- Histologically proven squamous carcinoma or adenocarcinoma of cervix
- Performance index WHO grade 0 or 1
- Patients below 65 years of age
- FIGO Stage IIB
- Normal ECG and Cardiovascular system
- Normal hematological parameters
- Normal renal and liver function tests
Exclusion
- Co-morbid conditions like medical renal disease
- Medical or Psychological condition that would preclude treatment
- H/o Previous treatment / Pregnancy
- Patient unreliable for treatment completion and follow-up.
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00193804
Start Date
February 1 2005
End Date
June 30 2019
Last Update
September 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400 012